GHS-R, growth hormone secretagogue receptor
Prescription medication is available only after evaluation and approval by a licensed healthcare provider, if clinically appropriate - approval is not guaranteed
Thus, clinical trials are needed to establish the benefits/risk profile in HF, considering that no properly designed, HF-specific randomised clinical trials have been completed with GLP-1 RAs in any of the HF phenotypes
WARNING: KEEP OUT OF REACH OF CHILDREN: Do not use if you are under 18 years of age, pregnant, nursing, or contemplating pregnancy
Green in NYC to ensure you are receiving a therapeutic dose of Accutane
Employers that offer coverage without clear rules may face significant cost increases